Concepedia

Author

Laura Archer

Dana-Farber Cancer Institute

Also Known As

L E Archer, L. Archer, L. E. Archer, L.E. Archer, Laura Archer, Laura E. Archer

41

Publications

2.8K

Citations

19

H-Index

85

Concepts

All Affiliations

Dana-Farber Cancer InstituteDuke Medical CenterDuke University HospitalDuke UniversityUniversity of Chicago
LA

About

Laura Archer is an author at Dana-Farber Cancer Institute specializing in medicine, oncology, and radiation oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

10

11

462

2

Health Sciences

5

5

329

3

Nursing

2

2

61

4

Education

1

1

16

5

Language Studies

1

1

16

Laura Archer

×

25

Publications

2K

Citations

19

H-Index

YearCitations

Bevacizumab Plus Interferon Alfa Compared With Interferon Alfa Monotherapy in Patients With Metastatic Renal Cell Carcinoma: CALGB 90206

Brian I. Rini, Susan Halabi, Jonathan E. Rosenberg,

Journal of Clinical Oncology

2008

906

Adherence and Persistence With Oral Adjuvant Chemotherapy in Older Women With Early-Stage Breast Cancer in CALGB 49907: Adherence Companion Study 60104

Ann H. Partridge, Laura Archer, Alice B. Kornblith,

Journal of Clinical Oncology

2010

126

Progression-Free Survival as a Predictor of Overall Survival in Men With Castrate-Resistant Prostate Cancer

Susan Halabi, Nicholas J. Vogelzang, San‐San Ou,

Journal of Clinical Oncology

2009

111

Optimal Management of Malignant Pleural Effusions (Results of CALGB 30102)

Todd L. Demmy, Lin Gu, Jack E. Burkhalter,

Journal of the National Comprehensive Cancer Network

2012

107

Zoledronic acid preserves bone mineral density in premenopausal women who develop ovarian failure due to adjuvant chemotherapy: Final results from CALGB trial 79809

Charles L. Shapiro, Susan Halabi, Vera Hárs,

European Journal of Cancer

2011

100

Trends in acute renal failure associated with coronary artery bypass graft surgery in the United States

Madhav Swaminathan, Andrew Shaw, Barbara G. Phillips‐Bute,

Critical Care Medicine

2007

76

Does Health-Related Quality of Life Improve for Advanced Pancreatic Cancer Patients Who Respond to Gemcitabine? Analysis of a Randomized Phase III Trial of the Cancer and Leukemia Group B (CALGB 80303)

Dorothy Romanus, Hedy L. Kindler, Laura Archer,

Journal of Pain and Symptom Management

2011

72

Quality of Life of Older Patients With Early-Stage Breast Cancer Receiving Adjuvant Chemotherapy: A Companion Study to Cancer and Leukemia Group B 49907

Alice B. Kornblith, Lan Lan, Laura Archer,

Journal of Clinical Oncology

2011

69

Factor V Leiden Mutation and Thromboembolism Risk in Women Receiving Adjuvant Tamoxifen for Breast Cancer

J. E. Garber, Susan Halabi, Sara M. Tolaney,

JNCI Journal of the National Cancer Institute

2010

62

Single‐dose pharmacokinetics and pharmacodynamics of anacetrapib, a potent cholesteryl ester transfer protein (CETP) inhibitor, in healthy subjects

Rajesh Krishna, Amit Garg, Deborah Panebianco,

British Journal of Clinical Pharmacology

2009

50

Page 1